GKIM
VERA icon

GW&K Investment Management’s Vera Therapeutics VERA Stock Holding History

GW&K Investment Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.84M Buy
112,722
+23,704
+27% +$883K 0.04% 281
2026
Q1 		$3.58M Sell
89,018
-24,735
-22% -$1.07M 0.03% 284
2025
Q4 		$5.76M Buy
113,753
+36,688
+48% +$1.3M 0.05% 269
2025
Q3 		$2.24M Sell
77,065
-142,963
-65% -$3.31M 0.02% 307
2025
Q2 		$5.18M Sell
220,028
-32,212
-13% -$724K 0.05% 267
2025
Q1 		$6.06M Buy
252,240
+65,635
+35% +$2.11M 0.06% 269
2024
Q4 		$7.89M Buy
+186,605
New +$8.26M 0.07% 269

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GW&K Investment Management's VERA Position: Q2 2026 in Review

GW&K Investment Management increased its Vera Therapeutics (VERA) stake by 27% in Q2 2026, buying an estimated $883K and bringing the position to 112,722 shares worth $4.84M. The position accounts for 0.04% of the portfolio, ranked #281.

GW&K Investment Management first reported a position in VERA in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.89M in Q4 2024. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • GW&K Investment Management held 112,722 shares of Vera Therapeutics worth $4.84M as of Q2 2026.
  • GW&K Investment Management bought 23,704 Vera Therapeutics shares in Q2 2026, an estimated $883K.
  • Vera Therapeutics made up 0.04% of GW&K Investment Management's portfolio in Q2 2026, its #281 holding.
  • GW&K Investment Management first reported a position in Vera Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • GW&K Investment Management's Vera Therapeutics position peaked at $7.89M in Q4 2024.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.